ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Contact
✕

Considering Clinical Trials: A Blog About Cancer Treatment Options
July 19, 2023
July 19, 2023
Categories
  • Editorials

7 Ways Advocates Have Enhanced ECOG-ACRIN’s Cancer Research Program

ECOG-ACRIN’s cancer research advocates recently reflected on their committee’s key accomplishments
Do you like it?
0 Read more
July 19, 2023
July 19, 2023
Categories
  • New Trials

Now Enrolling: The DIRECT study is testing how well FDG-PET/CT imaging can predict if treatment is working prior to surgery for patients with HER2-positive breast cancer

This study is for patients who have untreated, early-stage HER2-positive breast cancer
Do you like it?
0 Read more
July 19, 2023
July 19, 2023
Categories
  • New Trials

Now Enrolling: ComboMATCH treatment trial E4 is testing a new option for patients with advanced solid tumors that progress despite taxane chemotherapy

This study is for patients with solid tumors that are progressing after treatment with taxane therapies
Do you like it?
0 Read more
July 19, 2023
July 19, 2023
Categories
  • Ongoing Trials

A closer look at ECOG-ACRIN’s men’s cancer trials

These trials are exploring new treatment approaches for adults with prostate or penile cancer
Do you like it?
0 Read more

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Archives

  • July 2023
  • March 2023
  • January 2023
  • September 2022
  • June 2022
  • March 2022
  • December 2021
  • September 2021
  • June 2021
  • March 2021
  • October 2020
  • June 2020
  • February 2020
  • October 2019

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts

Tags

Acute lymphoblastic leukemia Advocacy Bladder cancer Breast cancer Caregiving ComboMATCH Communication De-escalation Head and neck cancer Health equity HER2+ breast cancer Immune system therapy Immunotherapy Kidney cancer Leukemia Lung cancer Lymphoma Mammography Melanoma Men's health Multiple myeloma Myeloma National Clinical Trials Network NCI-MATCH Neuropathy Pancreatic cancer Pancreatic cysts Patient care Patient education Penile cancer Personalized medicine Personalized screening Personalized treatment Precision medicine Prevention Prostate cancer Screening Side effects Smoldering multiple myeloma Squamous cell carcinoma Surveillance Survivorship Symptom management Targeted therapy Throat cancer
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2012-2022 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc